Cite Filings / WVE / 0000080255-20-001311
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SC 13G/A

Amended Statement of Ownership

Wave Life Sciences, Inc. · Filed 2020-02-14 · Acc 0000080255-20-001311

Documents 1

  • SC 13G/A Amended Statement of Ownership , wve13gadec19.txt

Around this filing

  • 2020-02-20 4 President and CEO sold 11,451 shares at $7.85 ($89,890)
  • 2020-02-20 4 Senior VP, Drug Discovery sold 3,188 shares at $7.85 ($25,026)
  • 2020-02-14 SC 13G/A Amended Statement of Ownership
  • 2020-02-14 SC 13G/A Amended Statement of Ownership
  • 2020-02-14 SC 13G/A Amended Statement of Ownership
  • 2020-02-14 SC 13G/A Amended Statement of Ownership
  • 2020-01-10 SC 13G/A Amended Statement of Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-11-16 SCHEDULE 13G/A · Maverick Capital, Ltd. 0.0%
  2. 2024-02-13 SC 13G/A · BB Biotech AG 3.7%
  3. 2023-02-14 SC 13G/A · BB Biotech AG 5.2%
  4. 2022-02-11 SC 13G/A · BB Biotech AG 7.8%
  5. 2021-02-12 SC 13G/A · BB Biotech AG 5.3%
  6. 2020-02-14 SC 13G/A · BB Biotech AG 7.0%
  7. 2019-12-23 SC 13G · BB Biotech AG 5.5%
Loading wve13gadec19.txt…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…